Hunan Warrant Pharmaceutical (688799.SH): Application for listing of the chemical raw material drug sulfosalbutamol sulfate approved.
Warner Pharmaceutical Factory (688799.SH) announced that its wholly-owned subsidiary, Hunan Warner Big Pharmaceutical Factory Chiral Drug Limited Company...
Hunan Warrant Pharmaceutical (688799.SH) announced that its wholly-owned subsidiary, Hunan Warner Pharmaceuticals Co., Ltd., has received the "Notice of Approval for Listing Application of Salbutamol Sulfate Chemical Raw Material" issued by the National Medical Products Administration (NMPA) (Notice No.: 2024YS01166), and it has been publicly disclosed on the "Registration Information Publicity Platform for Active Pharmaceutical Ingredients, Pharmaceutical Excipients, and Pharmaceutical Packaging Materials" of the Drug Evaluation Center (CDE) of the NMPA.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


